Cytokinetics shares owned by Moore Capital Management
Quarter-by-quarter ownership of Cytokinetics (CYTK) shares owned by Moore Capital Management
from 13F filings
Historical chart of Moore Capital Management investment in Cytokinetics
Tip: Access up to 7 years of quarterly data
All positions including Cytokinetics held by Moore Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Cytokinetics by Moore Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $418k | 5.0k | 83.49 |
| 2023-09-30 | $737k | 25k | 29.46 |
| 2023-06-30 | $816k | 25k | 32.62 |
| 2023-03-31 | $880k | 25k | 35.19 |
| 2022-12-31 | $1.1M | 25k | 45.82 |
| 2022-09-30 | $1.2M | 25k | 48.44 |
| 2022-06-30 | $2.0M | 50k | 39.30 |
| 2022-03-31 | $2.8M | 75k | 36.81 |
| 2021-12-31 | $4.6M | 100k | 45.58 |
| 2020-09-30 | $1.1M | 50k | 21.66 |
| 2017-06-30 | $605k | 50k | 12.10 |